Premium
Covalent Inhibition of HIV‐1 Integrase by N ‐Succinimidyl Peptides
Author(s) -
Chandra Koushik,
Das Priyadip,
Mamidi Samarasimhareddy,
Hurevich Mattan,
IosubAmir Anat,
Metanis Norman,
Reches Meital,
Friedler Assaf
Publication year - 2016
Publication title -
chemmedchem
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.817
H-Index - 100
eISSN - 1860-7187
pISSN - 1860-7179
DOI - 10.1002/cmdc.201600190
Subject(s) - succinimide , integrase , moiety , covalent bond , peptide , chemistry , residue (chemistry) , lysine , stereochemistry , combinatorial chemistry , amine gas treating , human immunodeficiency virus (hiv) , biochemistry , amino acid , biology , organic chemistry , dna , immunology
We present a new approach for the covalent inhibition of HIV‐1 integrase (IN) by an LEDGF/p75‐derived peptide modified with an N‐terminal succinimide group. The covalent inhibition is mediated by direct binding of the succinimide to the amine group of a lysine residue in IN. The peptide serves as a specific recognition sequence for the target protein, while the succinimide serves as the binding moiety. The combination of a readily synthesizable peptide precursor with easy and efficient binding to the target protein makes this approach a promising new strategy for designing lead compounds.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom